Mobile Lads Corp. (MOBO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -2.24 Million USD | 56.72% |
| 2021 | 141.31 Thousand USD | -29.21% |
| 2020 | -991.58 Thousand USD | 3.26% |
| 2019 | -1.02 Million USD | 0.0% |
| 2016 | -3.8 Million USD | -1149.37% |
| 2015 | -3557.08 USD | -1062.09% |
| 2014 | -284.71 Thousand USD | -231.08% |
| 2013 | -7400.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | -112.73 Thousand USD | 15.82% |
| 2023 Q2 | -110.14 Thousand USD | 2.3% |
| 2022 Q1 | -136.81 Thousand USD | 0.0% |
| 2022 FY | - USD | 56.72% |
| 2022 Q4 | -133.91 Thousand USD | 19.01% |
| 2022 Q3 | -165.34 Thousand USD | -226.82% |
| 2022 Q2 | -50.59 Thousand USD | 63.02% |
| 2021 FY | - USD | -29.21% |
| 2020 FY | - USD | 3.26% |
| 2019 FY | - USD | 0.0% |
| 2017 Q1 | -637.61 Thousand USD | -24.83% |
| 2016 Q4 | -510.78 Thousand USD | 76.7% |
| 2016 Q2 | -823.5 Thousand USD | -2628.02% |
| 2016 Q3 | -2.19 Million USD | -166.25% |
| 2016 Q1 | -30.18 Thousand USD | 16.88% |
| 2016 FY | - USD | -1149.37% |
| 2015 FY | - USD | -1062.09% |
| 2015 Q4 | -36.31 Thousand USD | 26.79% |
| 2015 Q3 | -49.6 Thousand USD | 51.82% |
| 2015 Q2 | -102.95 Thousand USD | -691.11% |
| 2015 Q1 | -13.01 Thousand USD | -525.97% |
| 2014 FY | - USD | -231.08% |
| 2014 Q1 | -2500.00 USD | 0.0% |
| 2014 Q2 | -1667.00 USD | 33.32% |
| 2014 Q4 | -2079.00 USD | 88.61% |
| 2014 Q3 | -18.25 Thousand USD | -995.02% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 96.845% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 62.199% |
| SQZ Biotechnologies Company | -64.14 Million USD | 96.506% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 87.098% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 102.383% |
| Mesoblast Limited | -62.38 Million USD | 96.408% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -45.904% |
| Genus plc | 73.7 Million USD | 103.041% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 66.102% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 36.815% |
| Marizyme, Inc. | -34.28 Million USD | 93.462% |
| ContraFect Corporation | -64.99 Million USD | 96.552% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 74.451% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 50.485% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -59.876% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 15.25% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 3.557% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -332.618% |
| Accustem Sciences Inc. | -3.74 Million USD | 40.179% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 95.353% |
| EV Biologics, Inc. | -1.26 Million USD | -76.869% |
| Q BioMed Inc. | -617.62 Thousand USD | -262.866% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 162.742% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -254.386% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 1.897% |
| Biomind Labs Inc. | -1.03 Million USD | -116.631% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 122.691% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 68.704% |
| Skye Bioscience, Inc. | -13.54 Million USD | 83.457% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -50.675% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -8864.636% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 42.302% |
| IMV Inc. | -35.52 Million USD | 93.691% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 85.878% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 10.424% |
| GB Sciences, Inc. | -1.41 Million USD | -57.841% |
| Alpha Cognition Inc. | -9.7 Million USD | 76.909% |
| HST Global, Inc. | -5303.00 USD | -42162.097% |
| CSL Limited | 4.78 Billion USD | 100.047% |
| Halberd Corporation | -74.27 Thousand USD | -2917.218% |
| Enzolytics Inc. | -2.12 Million USD | -5.614% |
| Resverlogix Corp. | -11.74 Million USD | 80.913% |
| Affymax, Inc. | -14.29 Million USD | 84.322% |
| SYBLEU INC | -141.57 Thousand USD | -1483.064% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 26.832% |
| argenx SE | -216.02 Million USD | 98.963% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 95.95% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 284.154% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -49.52% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 691.578% |
| AVAX Technologies, Inc. | -6.11 Million USD | 63.336% |
| Zenith Capital Corp. | -8.6 Million USD | 73.958% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.099% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -12764.698% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 8.392% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -1173.21% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 94.346% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 22.514% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -114.196% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 33430.741% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -28.066% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -16.672% |
| BioStem Technologies, Inc. | -7.55 Million USD | 70.33% |
| ONE Bio Corp. | 13.61 Million USD | 116.463% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -1137.608% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -8.953% |
| Agentix Corp. | -1.37 Million USD | -63.379% |
| LadRx Corporation | 412.28 Thousand USD | 643.597% |
| Cell Source, Inc. | -4.27 Million USD | 47.545% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -510.303% |
| Regen BioPharma, Inc. | 1.46 Million USD | 252.88% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -139.198% |
| NovAccess Global Inc. | -1.03 Million USD | -116.58% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 125.313% |
| Itoco Inc. | -1.86 Million USD | -19.913% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -490.369% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -100.821% |
| Kadimastem Ltd | -2.62 Million USD | 14.602% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -837.135% |
| CytoDyn Inc. | -18.02 Million USD | 87.569% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -2735.869% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -18226.593% |
| Qrons Inc. | -40.08 Thousand USD | -5491.575% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -361.45% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 524.918% |
| Rebus Holdings, Inc. | -951 Thousand USD | -135.663% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -111.03% |
| International Stem Cell Corporation | 202 Thousand USD | 1209.485% |
| Bioxytran, Inc. | -3.82 Million USD | 41.333% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -4157.521% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 8.967% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 93.752% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -4880.353% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 18.146% |
| Neutra Corp. | -181.24 Thousand USD | -1136.522% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 88.883% |
| PureTech Health plc | -11.62 Million USD | 80.725% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 88.882% |
| IXICO plc | -707 Thousand USD | -216.996% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 70.837% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 95.364% |
| CSL Limited | 4.73 Billion USD | 100.047% |
| Cellectis S.A. | -92.63 Million USD | 97.581% |